Lisa Marie Mendelson Assistant Professor of Medicine, Nurse Practitioner
Assistant Professor, Hematology & Medical Oncology
72 E. Concord Street | (617) 638-4317lmm1@bu.edu

Sections
Hematology & Medical Oncology
Centers
Amyloidosis Center
Biography
Lisa Mendelson has been a nurse practitioner at the Boston University Amyloidosis Center since 2017. She obtained her nurse practitioner degree from MGH Institute of Health Professions in 2010 and prior to coming to BU worked in private practice cardiology and hepatology in San Mateo, CA. In addition to her clinical practice she participates as a reviewer for multiple peer reviewed journals, is an active board member for the Amyloidosis Research Consortium-Patient Discovery and has authored multiple publications with a focus on amyloidosis awareness. She is the recipient of the BU Medical Group's 2019 clinical excellence award, 2024 National Daisy Award in Nursing.
Education
Nursing, MSN, MGH Institute of Health Professions
Nursing, BSN, MGH Institute of Health Professions
Psychology, BA, Emmanuel College
Publications
Sanchorawala V, Barroso B, Shelton A, Goetz E, Mendelson L, Joshi T, Burke N, Sloan JM, Staron A. Defying the odds: 30 years in AL amyloidosis research-recent barriers to clinical trial enrollment. Blood Adv. 2024 Nov 26; 8(22):5826-5828. PMID: 39293090.
Published on 11/4/2024Dodge MC, Prokaeva T, Mendelson L, Joshi T, Sanchorawala V, Kataria Y. High-Sensitivity and Conventional Cardiac Troponin-I Assays in AL Amyloidosis. J Appl Lab Med. 2024 Nov 04. PMID: 39495058.
Published on 9/14/2024Staron A, Mendelson LM, Joshi T, Burke N, Sanchorawala V. Factors impeding organ recovery despite a deep haematological response in patients with systemic AL amyloidosis. Br J Haematol. 2024 Dec; 205(6):2268-2272. PMID: 39275899.
Published on 9/11/2024Anand SK, Staron A, Mendelson LM, Joshi T, Burke N, Sanchorawala V, Verma A. Machine-learning based subgroups of AL amyloidosis and cumulative incidence of mortality and end stage kidney disease. Am J Hematol. 2024 Nov; 99(11):2140-2151. PMID: 39257247.
Published on 10/24/2023Gustine JN, Staron A, Mendelson L, Joshi T, Gopal DM, Siddiqi OK, Ruberg FL, Sanchorawala V. Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis. Blood Adv. 2023 Oct 24; 7(20):6080-6091. PMID: 37581513.
Published on 6/1/2023Gustine JN, Szalat RE, Staron A, Joshi T, Mendelson L, Sloan JM, Sanchorawala V. Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes. Haematologica. 2023 Jun 01; 108(6):1680-1684. PMID: 36546447.
Published on 5/4/2023Mendelson L, Prokaeva T, Lau KHV, Sanchorawala V, McCausland K, Spencer B, Dasari S, McPhail ED, Kaku MC. Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions. Amyloid. 2023 Dec; 30(4):357-363. PMID: 37140928.
Published on 1/31/2023Staron A, Mendelson LM, Joshi T, Ruberg FL, Sanchorawala V. Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre. Amyloid. 2023 Sep; 30(3):297-302. PMID: 36718932.
Published on 8/24/2022Alreshq R, Cozzolino M, Lilleness B, Pipilas A, Mendelson L, Joshi T, Muralidhar V, Guardino E, Berk JL, Siddiqi OK, Gopal DM, Sanchorawala V, Ruberg FL. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging. Am J Cardiol. 2022 Oct 15; 181:105-112. PMID: 36028388.
Published on 7/25/2022Fogaren T, Shelton AC, Faller DV, Stull DM, Thuenemann S, Mendelson L. Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses. Clin J Oncol Nurs. 2022 Jul 25; 26(4):421-432. PMID: 35939729.
Media Mentions
Published on 5/15/2024
How Well Are You Managing Transthyretin Amyloidosis (ATTR)?
View full list of 1 media mentions.